H2 Phenotype Annotations - Multigenic Genotypes

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

H2
histocompatibility-2, MHC
MGI:95894

89 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Aire^tm1.1Doi/Aire^tm1.1Doi H2^b/H2^b NOD.Cg-Aire^tm1.1Doi H2^b/Doi	abnormal pancreas physiology	J:107432
	stomach inflammation	J:107432
Apobec3^Gt(XN450)Byg/Apobec3^Rfv3-s H2^b/H2^b involves: A.BY * C57BL/6	abnormal immunoglobulin level	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Rfv3-s H2^b/H2^d involves: BALB/c * C57BL/6	abnormal immunoglobulin level	J:138778
	increased susceptibility to Retroviridae infection	J:138778
	increased susceptibility to Retroviridae infection induced morbidity/mortality	J:138778
Dh/Dh⁺ H2^d/H2^d NZB.Cg-Dh	absent spleen	J:12036
	cryptorchism	J:12036
	decreased B cell proliferation	J:12036
	decreased IgG1 level	J:12036
	decreased IgG level	J:12036
	decreased IgM level	J:12036
	decreased lymphoma incidence	J:12036
	decreased susceptibility to graft versus host disease	J:12036
	glomerulonephritis	J:12036
	increased anti-erythrocyte antigen antibody level	J:12036
	increased anti-nuclear antigen antibody level	J:12036
	increased anti-single stranded DNA antibody level	J:12036
	increased autoantibody level	J:12036
	increased T cell proliferation	J:12036
	polyphalangy	J:12036
	reduced female fertility	J:12036
	reduced fertility	J:12036
H2^b/H2^b Itk^tm1Ljb/Itk^tm1Ljb Tg(TcrAND)53Hed/? involves: C3H/HeJ * C57BL/6 * C57BL/10	abnormal positive T cell selection	J:123795
	decreased CD4-positive, alpha-beta T cell number	J:123795
H2^b/H2^b Nfkbid^tm1Clay/Nfkbid^tm1Clay Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6	abnormal thymocyte activation	J:132071
	decreased interleukin-2 secretion	J:132071
	decreased T cell proliferation	J:132071
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo involves: 129P2/OlaHsd	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
	spleen hypoplasia	J:131357
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo Tg(TcraH-Y,TcrbH-Y)71Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal T cell differentiation	J:131357
H2^b/H2^b Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra19,Tcrb19)#Stl/0 involves: 129S7/SvEvBrd * C57BL/6	normal immune system phenotype	J:19795
H2^b/H2^b Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? involves: 129S/SvEv * C57BL/6	abnormal cytotoxic T cell physiology	J:133112
	arrested T cell differentiation	J:133112
	decreased CD4-positive, alpha-beta T cell number	J:133112
	increased CD8-positive, alpha-beta T cell number	J:133112
	increased T cell proliferation	J:133112
H2^b/H2^b Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
H2^b/H2^b Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
H2^b/H2^b Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal double-negative T cell morphology	J:131357
	abnormal double-positive T cell morphology	J:81564
	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
H2^b/H2^d Tg(Ins2-E3)1Dvs/0 involves: BALB/c * C57BL/6 * DBA/2J	increased length of allograft survival	J:109763
H2^b/H2^d Tg(TcraTcrb)1100Mjb/? involves: BALB/c * C57BL/6	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^b/H2^d Themis^tm1Gasc/Themis^tm1Gasc involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2	abnormal negative T cell selection	J:151074
H2^b/H2^g7 Tg(TcraR28,TcrbR28)KRNDim/0 involves: C57BL/6 * NOD * SJL	abnormal mitral valve morphology	J:275827
	increased hydroxyproline level	J:275827
	mitral valve inflammation	J:275827
	rheumatoid arthritis	J:36815, J:275827
	thick mitral valve	J:275827
H2^b/H2^k Itk^tm1Ljb/Itk^tm1Ljb Tg(TcrAND)53Hed/? involves: C3H/HeJ * C57BL/6 * C57BL/10	abnormal positive T cell selection	J:123795
	decreased CD4-positive, alpha-beta T cell number	J:123795
H2^b/H2^k Tg(TcraTcrb)1100Mjb/? involves: C57BL/6 * C57BL/10Sg * C57BR/c	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^b/H2^s Tg(TcraTcrb)1100Mjb/? involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^d/H2^d Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? involves: 129S/SvEv * C57BL/6	arrested T cell differentiation	J:133112
	decreased CD4-positive, alpha-beta T cell number	J:133112
	decreased CD8-positive, alpha-beta T cell number	J:133112
H2^d/H2^d Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/0 involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
H2^d/H2^d Tg(TcraP1.5,TcrbP1.5)29Amsv/0 Trap1a^tm1.1Jvde/Y involves: 129 * BALB/cJ * C57BL/10 * DBA/2	abnormal T cell clonal deletion	J:180807
H2^d/H2^d Trap1a^tm1.1Jvde/Y involves: 129 * BALB/cJ * C57BL/10 * DBA/2	abnormal CD8-positive, alpha-beta T cell physiology	J:180807
	abnormal immune tolerance	J:180807
	decreased susceptibility to induced morbidity/mortality	J:180807
	normal reproductive system phenotype	J:180807
	tumor regression	J:180807
H2^d/H2^d Trap1a^tm1.1Jvde/Trap1a^tm1.1Jvde involves: 129 * BALB/cJ * C57BL/10 * DBA/2	normal reproductive system phenotype	J:180807
H2^dlAb1-Ea/H2^dlAb1-Ea Marchf1^tm1.1Sish/Marchf1^tm1.1Sish involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6	normal immune system phenotype	J:157516
H2^dlAb1-Ea/H2^dlAb1-Ea Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} involves: 129S2/SvPas * C57BL/6	abnormal T cell differentiation	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
H2^dlAb1-Ea/H2^dlAb1-Ea Rag1^tm1Mom/Rag1^tm1Mom Tg(HLA-DRA,HLA-DRB50101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 involves: 129S2/SvPas 129S7/SvEvBrd * C57BL/6	brain inflammation	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Rag1^tm1Mom/Rag1^tm1Mom Tg(HLA-DRA,HLA-DRB50101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 involves: 129S2/SvPas 129S7/SvEvBrd * C57BL/6	brain inflammation	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em2Kap/Rr381^em2Kap involves: 129S2/SvPas * C57BL/6	absent CD4-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em4Kap/Rr381^em4Kap involves: 129S2/SvPas * C57BL/6	absent CD8-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em5Kap/Rr381^em5Kap involves: 129S2/SvPas * C57BL/6	absent CD8-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)hiKito/0 involves: 129S2/SvPas C57BL/6	normal nervous system phenotype	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 involves: 129S2/SvPas C57BL/6	abnormal axon morphology	J:189816
	abnormal cytokine secretion	J:189816
	abnormal motor capabilities/coordination/movement	J:189816
	axon degeneration	J:189816
	brain inflammation	J:189816
	CNS inflammation	J:189816
	increased CD4-positive, alpha-beta T cell number	J:189816
	increased inflammatory response	J:189816
	increased interferon-gamma secretion	J:189816
	increased interleukin-17 secretion	J:189816
	increased susceptibility to experimental autoimmune encephalomyelitis	J:189816
	increased T-helper 1 cell number	J:189816
	increased T-helper 17 cell number	J:189816
	neuron degeneration	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 involves: 129S2/SvPas C57BL/6	brain inflammation	J:189816
	increased susceptibility to experimental autoimmune encephalomyelitis	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(TRATL3A6,TRBTL3A6)#Kito/0 involves: 129S2/SvPas * C57BL/6	normal nervous system phenotype	J:189816
H2^g7/H2^g7 Ins2^tm1Jja/Ins2^tm1Jja Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD	increased circulating glucose level	J:111874
	increased susceptibility to autoimmune diabetes	J:111874
H2^g7/H2^g7 Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD	increased susceptibility to autoimmune diabetes	J:111874
	insulitis	J:111874
H2^g7/H2^g7 Tg(Ins2-Vtcn1)#Xxz/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 involves: C57BL/6 * NOD * SJL	decreased interferon-gamma secretion	J:177612
	decreased interleukin-17 secretion	J:177612
	decreased regulatory T cell number	J:177612
	decreased susceptibility to autoimmune diabetes	J:177612
H2^g7/H2^g7 Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 B6.NOD-(D17Mit21-D17Mit10) Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs	increased susceptibility to autoimmune diabetes	J:167508
H2^g7/H2^g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 B6.Cg-H2^g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi	decreased susceptibility to autoimmune diabetes	J:86926
H2^g7/H2^g7 Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD	decreased susceptibility to autoimmune diabetes	J:111874
	insulitis	J:111874
H2^g7/H2^q Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD	increased susceptibility to autoimmune diabetes	J:111874
H2^k/H2^k Tg(TcraTcrbAD10)1Hed/? involves: C57BL/6 * SJL	increased CD4-positive, alpha-beta T cell number	J:124701
H2^q/H2^q Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD	decreased susceptibility to autoimmune diabetes	J:111874
	normal digestive/alimentary phenotype	J:111874
H2^q/? Ncf1^m1J/Ncf1^m1J B6.Cg-Ncf1^m1J H2^q	decreased susceptibility to experimental autoimmune encephalomyelitis	J:92437
	increased susceptibility to experimental autoimmune encephalomyelitis	J:92437
	increased susceptibility to induced arthritis	J:92437
	increased susceptibility to type IV hypersensitivity reaction	J:92437
	rheumatoid arthritis	J:92437
H2^u/H2^u Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra19,Tcrb19)#Stl/0 either: (involves: 129S7/SvEvBrd * C57BL/6 * PL/J) or (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * PL/J)	increased susceptibility to autoimmune disorder	J:19795
	limb paralysis	J:19795
H2^u/H2^u Tg(Tcra19,Tcrb19)#Stl/0 either: (involves: C57BL/6 * PL/J) or (involves: C57BL/6 * C57BL/10 * PL/J)	increased susceptibility to autoimmune disorder	J:19795
	increased susceptibility to experimental autoimmune encephalomyelitis	J:19795
H2^u/H2^u Tg(TCRA)B1Jg/0 B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRA)B1Jg/J	abnormal thymus cell ratio	J:92992
	decreased CD4-positive, alpha-beta T cell number	J:92992
	decreased double-positive T cell number	J:92992
	decreased thymocyte number	J:92992
	increased double-negative T cell number	J:92992
	increased T cell derived lymphoma incidence	J:92992
H2^u/H2^u Tg(TCRA)B1Jg/0 Tg(TCRB)C14Jg/0 B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg	abnormal double-negative T cell morphology	J:92992
	abnormal double-positive T cell morphology	J:92992
	abnormal thymus cell ratio	J:92992
	absent gamma-delta T cells	J:92992
	decreased double-positive T cell number	J:92992
	increased CD4-positive, alpha-beta T cell number	J:92992
	increased double-negative T cell number	J:92992
	increased T cell derived lymphoma incidence	J:92992
H2^u/H2^u Tg(TCRA)B1Jg/? Tg(TCRB)C14Jg/? involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J	abnormal CD4-positive, alpha-beta T cell physiology	J:92991
	abnormal effector T cell morphology	J:92991
	decreased CD8-positive, alpha-beta T cell number	J:92991
	decreased double-positive T cell number	J:92991
	increased autoantibody level	J:92991
	increased CD4-positive, alpha-beta T cell number	J:92991
	increased susceptibility to experimental autoimmune encephalomyelitis	J:92991
	paralysis	J:92991
H2^u/H2^u Tg(TCRB)C14Jg/0 B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRB)C14Jg/J	abnormal double-negative T cell morphology	J:92992
	abnormal double-positive T cell morphology	J:92992
	absent gamma-delta T cells	J:92992
Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} H2^b/H2^b Tg(Tcrb)93Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal double-negative T cell morphology	J:131357
	abnormal double-positive T cell morphology	J:81564
	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} H2^d/H2^d Ptcra^tm1Vbo/Ptcra^tm1Vbo Tg(Tcrb)93Vbo/? involves: 129P2/OlaHsd * C57BL/6J * DBA/2J	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24